Cerevel Therapeutics Holdings, Inc. EBITDA Margin 2021-2024 | CERE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cerevel Therapeutics Holdings, Inc. (CERE) over the last 10 years. The current EBITDA margin for Cerevel Therapeutics Holdings, Inc. as of March 31, 2024 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
